We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
151
Caterpillar
CAT
$399B
$447K 0.04%
3,279
+6
+0.2% +$793
CLX icon
152
Clorox
CLX
$11.6B
$440K 0.04%
2,875
+944
+49% +$144K
RVTY icon
153
Revvity
RVTY
$12B
$438K 0.04%
4,546
– –
NEOG icon
154
Neogen
NEOG
$2.22B
$437K 0.04%
14,056
– –
DELL icon
155
Dell
DELL
$250B
$429K 0.04%
16,658
-253
-1% -$7.89K
NOVT icon
156
Novanta
NOVT
$5.19B
$425K 0.04%
4,511
-97
-2% -$8.28K
CME icon
157
CME Group
CME
$89B
$424K 0.04%
2,186
+92
+4% +$17K
RJF icon
158
Raymond James Financial
RJF
$32.7B
$423K 0.04%
7,502
+17
+0.2% +$969
UNP icon
159
Union Pacific
UNP
$177B
$420K 0.04%
2,485
+19
+0.8% +$3.26K
CDW icon
160
CDW
CDW
$16.8B
$419K 0.04%
3,775
+10
+0.3% +$1.05K
A icon
161
Agilent Technologies
A
$37.3B
$415K 0.04%
5,564
+7
+0.1% +$519
MPC icon
162
Marathon Petroleum
MPC
$93.2B
$413K 0.04%
7,399
+53
+0.7% +$2.9K
AXP icon
163
American Express
AXP
$241B
$406K 0.04%
3,286
+17
+0.5% +$2K
TRV icon
164
Travelers Companies
TRV
$78.2B
$402K 0.04%
2,690
-14,402
-84% -$2.08M
QQQX icon
165
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.45B
$399K 0.04%
17,824
-2,055
-10% -$46K
BAX icon
166
Baxter International
BAX
$11.5B
$398K 0.04%
4,859
+5
+0.1% +$388
ZION icon
167
Zions Bancorporation
ZION
$10.5B
$380K 0.03%
8,273
+38
+0.5% +$1.76K
XLB icon
168
State Street Materials Select Sector SPDR ETF
XLB
$8.3B
$378K 0.03%
+12,936
New +$365K
BIOX icon
169
Bioceres Crop Solutions
BIOX
$21.7M
$373K 0.03%
70,358
– –
BLK icon
170
Blackrock
BLK
$164B
$366K 0.03%
780
+20
+3% +$9.05K
VLO icon
171
Valero Energy
VLO
$93.9B
$364K 0.03%
4,249
-64
-1% -$5.28K
BABA icon
172
Alibaba
BABA
$291B
$362K 0.03%
2,138
-255
-11% -$44K
IYG icon
173
iShares US Financial Services ETF
IYG
$2.12B
$358K 0.03%
8,025
– –
CTAS icon
174
Cintas
CTAS
$80.7B
$352K 0.03%
5,928
– –
PEG icon
175
Public Service Enterprise Group
PEG
$38.7B
$336K 0.03%
5,707
+34
+0.6% +$2.03K
5 6
7
8 9

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.